GAMCO Investors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

GAMCO Investors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-52,850	Closed	-$1.11M	–	855
2016 Q3	$1.11M	Buy	+52,850	New	+$609K	0.01%	560

GAMCO Investors's VTAE Position: Q4 2016 in Review

GAMCO Investors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 52,850 shares — an estimated $1.11M sold.

GAMCO Investors first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $1.11M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

GAMCO Investors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
GAMCO Investors sold 52,850 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.11M.
GAMCO Investors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
GAMCO Investors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.11M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on GAMCO Investors's 13F filing for Q4 2016, filed 10 Feb 2017.